Optimal Maintenance Therapy With Bevacizumab After Induction in Metastatic Colorectal Cancer (CRC)

NCT00973609 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

853

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Neoplasms

Interventions

DRUG: 5-Fluorouracil, Folic acid, Capecitabine; Bevacizumab
DRUG: 5-Fluorouracil, Folic acid, Capecitabine; Bevacizumab
DRUG: 5-Fluorouracil, Folic acid, Capecitabine; Bevacizumab

Sponsor

AIO-Studien-gGmbH

Collaborators

[object Object]